Moderate to severe toxicity was slightly reduced in the cetuximab arm but overall similar and differences did not reach statistical significance.
← all excerpts
The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective.
1
—
—